61
Participants
Start Date
November 30, 2014
Primary Completion Date
April 30, 2021
Study Completion Date
April 30, 2021
Naloxegol
Opioid Antagonist
Odense University Hospital, Odense
Haukeland Universitetssykehus, Bergen
St. Olavs Hospital, Trondheim
Hospital Infantil Universitario Nino Jesus, Madrid
Hospital Universitario Madrid Sanchinarro, Madrid
Unidad de Hematología y Oncología Pediátrica - Hospital Universitario HM Monteprincipe, Madrid
Rambam Medical Center, Oncology Institute, Haifa
Schneider Children Medical Center, Petah Tikva
Oslo University Hospital - Rikshospitalet, Oslo
Pediatric Oncology Unit Hospital Vall d'Hebron, Barcelona
Hospital Universitario Virgen de la Arrixaca, Murcia
The Leeds Teaching Hosptial NHS Trust, Leeds
Alder Hey Children's Hospital, Liverpool
Royal Marsden Hospital, London
Nottingham Children's Hospital, Nottingham
Oxford University Hospitals NHS Foundation Trust, Oxford
Lead Sponsor
Kyowa Kirin Pharmaceutical Development Ltd
INDUSTRY